�鶹��ý

Adam Cooper focuses his practice on health care regulatory compliance, transactions, and reimbursement matters. He advises hospitals, health systems, ambulatory surgery centers, physician practices, value-based care organizations, and ancillary providers, including durable medical equipment suppliers, pharmacies, home health and hospice agencies, laboratories, independent diagnostic testing facilities, skilled nursing facilities, long-term care facilities, and medical device manufacturers and distributors, on regulatory issues affecting their operations, growth strategies, and transactions.

Adam regularly counsels clients on federal and state health care regulatory requirements, including the Stark Law, Anti-Kickback Statute, Civil Monetary Penalties Law, corporate practice of medicine restrictions, contracting, reimbursement, Medicare and Medicaid enrollment, licensure, and change-of-ownership considerations. He also assists clients with internal investigations, government and commercial payor audits, overpayment appeals, UPIC and Medicare Advantage matters, payment suspensions, PTAN revocations, and responses to inquiries, investigations, and other actions by federal and state regulatory bodies.

In transactional matters, Adam advises clients on the regulatory aspects of health care mergers, acquisitions, investments, and platform growth strategies, including diligence, deal structuring, licensure, enrollment, reimbursement, ownership disclosure, and post-closing compliance planning. He has particular experience supporting transactions and advisory matters involving ambulatory surgery centers, sleep medicine and testing businesses, DME suppliers, physician practices, telehealth and remote patient monitoring arrangements, and other ancillary provider models.